Repetitive transcranial magnetic stimulation (rTMS) is an effective intervention in major depressive disorder (MDD), with superior tolerability over medication [1]. Unfortunately, its widespread adoption has been impeded by high operational costs, decreasing accessibility.
No takes yet. Share an insight, caveat, or question.
Miron et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: